Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial

Publication date: Available online 2 March 2021Source: The Lancet HaematologyAuthor(s): Fabian Frontzek, Marita Ziepert, Maike Nickelsen, Bettina Altmann, Bertram Glass, Mathias Haenel, Lorenz Truemper, Gerhard Held, Martin Bentz, Peter Borchmann, Martin Dreyling, Andreas Viardot, Frank P Kroschinsky, Bernd Metzner, Annette M Staiger, Heike Horn, German Ott, Andreas Rosenwald, Markus Loeffler, Georg Lenz
Source: The Lancet Haematology - Category: Hematology Source Type: research